Amarin Corp Plc (AMRN)

[Atom0aks]

Need some insight to this. Below is a cut and past commentary from some guy playing mind games on Stocktwits. He reminds me of MRC. Nevertheless, my question pertains to his comment around TRILOGY 1. Anyone know what he is talking about?. See below.


Sep 15th, 2:28 pm
$AMRN Posters are sounding a bit frazzled on this board today. There’s bickering about mineral oil. Criticism of members for posting 2-day old positive equity coverage. And, curiously, a long poster professing his “love” for me. I don’t know what to say except to remind all of you that TRILOGY1 data will be released to the public prior to Vascepa's PDUFA date of December 28th. Maybe even before the November 14th adcom. That will have a far greater effect on the outcome of the Vascepa sNDA than EVAPORATE ever could. GLTA

EDIT: Nevermind, his argument pertains to the use of mineral oil as a placebo.

Source: https://stocktwits.com/ScryingBiotech/message/177605808

Here is study info:
https://clinicaltrials.gov/ct2/show/NCT03398005

This is the drug being studied:
https://www.acastipharma.com/en/capre

It doesn't look like the study is measuring cardiovascular outcomes, so I am not sure what is the connection to Amarin's sNDA.